Latest filing published 22 May 2025 for Integrated Biopharma INC, €11k. Read the official filing
All filings by Dina Masi on record concern Integrated Biopharma Inc. We count 3 filings; the first trade dates from 20 September 2023 and the latest from 21 May 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 22 May 2025: a share grant of €11k, in Integrated Biopharma Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations